Shortage of organs for transplants holds the responsibility of boosting the 3D bioprinting market revenue. 3D bioprinting plays a vital role in tissue engineering, which means fabricating functional tissue for applications in drug testing and regenerative medicine.
Tissue reconstruction and regeneration thus facilitate the probability of reconstructing or repairing damaged organs. The cosmetics sector involving skin grafting also gets benefited by 3D bioprinting.
The key players in 3D bioprinting market are looking to collaborate with research institutes to develop a new method for bioprinting the functional human brain tissue. Such developments are bound to be the turning points with regards to laying foundation of the fabrication of complex tissue structures during the forecast period.
3D bioprinting is a technology in which bioinks are mixed with the living cells and printed in 3D in order to construct natural, tissue-like, 3D structures.
At present, this technology is used in tissue engineering, skin grafting, and development of new drugs. 3D bioprinted structures are more biologically relevant as compared to the in-vitro studies conducted in 2D.
Clinical settings such as bone grafts and 3D printed skin, implants, and even the printed organs in entirety are the centerpoints of bioprinting research in the present scenario.
The advantages of 3D bioprinting include 100% imitation of real structure of the desired organ/tissue, biocompatibility with the human tissues and cells, and precise examination of effects of drugs.
However, maintenance of cell environment for 3D bioprinting can be difficult. This factor is likely to restrain the 3D bioprinting market during the forecast period.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
As per the United Network for Organ Sharing, the year 2022 witnessed 42,800 organ transplants, out of which, kidney transplants exceeded by 25,000 as compared to the year 2021. However, as per an article published by World Economic Forum, organ shortage persists.
As per Medical Device Network, over 110,000 individuals are waiting for organ transplants as of now in the U.S. alone, and 20 give in to this shortage everyday. Rise in demand for these transplants is driving the need for 3D bioprinting.
The healthcare organizations, research institutions, and hi-tech companies are collaborating to use 3D bioprinting in organ and tissue transplantation.
3D bioprinting helps in creation of images of organs that can closely imitate the functionality and structure of natural organs. 3D printing of kidneys, heart, livers, and various other vital organs is thus prompting the healthcare personnel to move toward regenerative medicine.
Continuous demand for organ transplants is thus expanding the 3D bioprinting market size.
Numerous governments worldwide have banned animal testing for serving cosmetic purposes. Therefore, the companies operating in the cosmetics sector are looking for methods of ethical testing on several types of skin, so that customized formulations can be produced.
Moreover, as human skin is multi-layered, 3D bioprinting presents an exclusive ability of depositing cells in scrupulous arrangements that are analogous to actual human skin, thereby resulting in formation of cheaper, quicker, and more efficient testing procedures.
Companies such as Procter & Gamble and L’Oréal are investing significantly into research regarding 3D bioprinting with an objective of revolutionizing dermatology in future.
One of the latest 3D bioprinting market trends regarding cosmetic vertical is that of creating 3D printed customized face masks and ocular patches.
Need to refurbish skin tones without involving animals for trials is thus driving the 3D bioprinting market growth.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest 3D bioprinting market analysis, North America held the largest share of three-dimensional bioprinting landscape and the dominance is expected to continue even during the forecast period. This is attributed to the government of the U.S. spending exorbitantly on R&D activities pertaining to devising vaccines.
Asia Pacific also holds a noticeable share in 3D biological printing industry due to extensive research conducted with respect to bio-manufacturing. China leads the market for three-dimensional tissue engineering with Tsinghua University being one of the leading labs in 3D bioprinting and additive manufacturing.
3D bioprinting market manufacturers are expanding their footprint through inorganic modes of development. For instance, in June 2022, REGEMAT 3D announced that it had entered into partnership with Humabiologics, a company known to provide human-derived biomaterials for regenerative medicine, with the objective of serving a wider life sciences-based customer base constituting academic institutions and industry partners in Europe.
Key participants are also launching new products to sustain themselves. For instance, in November 2023, Stratasys launched the F3300 Fused Deposition Modelling (FDM) 3D printing technology, which has quicker extrusion, gantry speeds, and auto-calibration.
Organovo Holdings, Inc., Bico Group, Stratasys, Ltd., EnvisionTEC, REGEMAT 3D S.L., Aspect Biosystems, 3D Systems Corporation, Nuclera, Inventia Life Science, Allevi, and OxSyBio are some of the key players covered in the 3D bioprinting market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 1.6 Bn |
| Market Forecast (Value) in 2034 | US$ 5.7 Bn |
| Growth Rate (CAGR) | 12.2% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 1.6 Bn in 2023
It is projected to grow at a CAGR of 12.2% from 2024 to 2034
Need for organ transplants and growing use in cosmetic industries
Hospitals segment accounted for the largest share in 2023
North America was the dominant region in 2023
Organovo Holdings, Inc., Bico Group, Stratasys, Ltd., EnvisionTEC, REGEMAT 3D S.L., Aspect Biosystems, 3D Systems Corporation, Nuclera, Inventia Life Science, Allevi, and OxSyBio
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: 3D Bioprinting Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. 3D Bioprinting Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global 3D Bioprinting Market Analysis and Forecast, by Component
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Component, 2020-2034
6.3.1. 3D Bioprinters
6.3.2. Bioinks
6.4. Market Attractiveness Analysis, by Component
7. Global 3D Bioprinting Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Research Applications
7.3.2. Clinical Applications
7.4. Market Attractiveness Analysis, by Application
8. Global 3D Bioprinting Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Biopharmaceutical Companies
8.3.3. Research Organizations and Academic Institutes
8.4. Market Attractiveness Analysis, by End-user
9. Global 3D Bioprinting Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America 3D Bioprinting Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Component, 2020-2034
10.3.1. 3D Bioprinters
10.3.2. Bioinks
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Research Applications
10.4.2. Clinical Applications
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals
10.5.2. Biopharmaceutical Companies
10.5.3. Research Organizations and Academic Institutes
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Component
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe 3D Bioprinting Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Component, 2020-2034
11.3.1. 3D Bioprinters
11.3.2. Bioinks
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Research Applications
11.4.2. Clinical Applications
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals
11.5.2. Biopharmaceutical Companies
11.5.3. Research Organizations and Academic Institutes
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Component
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific 3D Bioprinting Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Component, 2020-2034
12.3.1. 3D Bioprinters
12.3.2. Bioinks
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Research Applications
12.4.2. Clinical Applications
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals
12.5.2. Biopharmaceutical Companies
12.5.3. Research Organizations and Academic Institutes
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Component
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America 3D Bioprinting Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Component, 2020-2034
13.3.1. 3D Bioprinters
13.3.2. Bioinks
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Research Applications
13.4.2. Clinical Applications
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals
13.5.2. Biopharmaceutical Companies
13.5.3. Research Organizations and Academic Institutes
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Component
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa 3D Bioprinting Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Component, 2020-2034
14.3.1. 3D Bioprinters
14.3.2. Bioinks
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Research Applications
14.4.2. Clinical Applications
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals
14.5.2. Biopharmaceutical Companies
14.5.3. Research Organizations and Academic Institutes
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Component
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Organovo Holdings, Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Bico Group
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Stratasys, Ltd.
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. EnvisionTEC
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. REGEMAT 3D S.L.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Aspect Biosystems
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. 3D Systems Corporation
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Nuclera
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Inventia Life Science
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Allevi
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. OxSyBio
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Others
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
List of Tables
Table 01: Global 3D Bioprinting Market Size (US$ Mn) Forecast, by Component, 2020-2034
Table 02: Global 3D Bioprinting Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 03: Global 3D Bioprinting Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: Global 3D Bioprinting Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 05: North America 3D Bioprinting Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 06: North America 3D Bioprinting Market Size (US$ Mn) Forecast, by Component, 2020-2034
Table 07: North America 3D Bioprinting Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 08: North America 3D Bioprinting Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 09: Europe 3D Bioprinting Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe 3D Bioprinting Market Size (US$ Mn) Forecast, by Component, 2020-2034
Table 11: Europe 3D Bioprinting Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 12: Europe 3D Bioprinting Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific 3D Bioprinting Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific 3D Bioprinting Market Size (US$ Mn) Forecast, by Component, 2020-2034
Table 15: Asia Pacific 3D Bioprinting Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 16: Asia Pacific 3D Bioprinting Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Latin America 3D Bioprinting Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America 3D Bioprinting Market Size (US$ Mn) Forecast, by Component, 2020-2034
Table 19: Latin America 3D Bioprinting Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 20: Latin America 3D Bioprinting Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa 3D Bioprinting Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa 3D Bioprinting Market Size (US$ Mn) Forecast, by Component, 2020-2034
Table 23: Middle East & Africa 3D Bioprinting Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 24: Middle East & Africa 3D Bioprinting Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global 3D Bioprinting Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global 3D Bioprinting Market Revenue (US$ Mn), by Component, 2023
Figure 03: Global 3D Bioprinting Market Value Share, by Component, 2023
Figure 04: Global 3D Bioprinting Market Revenue (US$ Mn), by Application, 2023
Figure 05: Global 3D Bioprinting Market Value Share, by Application, 2023
Figure 06: Global 3D Bioprinting Market Revenue (US$ Mn), by End-user, 2023
Figure 07: Global 3D Bioprinting Market Value Share, by End-user, 2023
Figure 08: Global 3D Bioprinting Market Value Share, by Region, 2023
Figure 09: Global 3D Bioprinting Market Value (US$ Mn) Forecast, 2020-2034
Figure 10: Global 3D Bioprinting Market Value Share Analysis, by Component, 2023 and 2034
Figure 11: Global 3D Bioprinting Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global 3D Bioprinting Market Value Share Analysis, by Application, 2023 and 2034
Figure 13: Global 3D Bioprinting Market Attractiveness Analysis, by Application, 2024-2034
Figure 14: 3D Bioprinting Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global 3D Bioprinting Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global 3D Bioprinting Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global 3D Bioprinting Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America 3D Bioprinting Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America 3D Bioprinting Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America 3D Bioprinting Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America 3D Bioprinting Market Value Share Analysis, by Component, 2023 and 2034
Figure 22: North America 3D Bioprinting Market Value Share Analysis, by Application, 2023 and 2034
Figure 23: North America 3D Bioprinting Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America 3D Bioprinting Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America 3D Bioprinting Market Attractiveness Analysis, by Application, 2024-2034
Figure 26: North America 3D Bioprinting Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe 3D Bioprinting Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe 3D Bioprinting Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe 3D Bioprinting Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe 3D Bioprinting Market Value Share Analysis, by Component, 2023 and 2034
Figure 31: Europe 3D Bioprinting Market Value Share Analysis, by Application, 2023 and 2034
Figure 32: Europe 3D Bioprinting Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe 3D Bioprinting Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe 3D Bioprinting Market Attractiveness Analysis, by Application, 2024-2034
Figure 35: Europe 3D Bioprinting Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific 3D Bioprinting Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific 3D Bioprinting Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific 3D Bioprinting Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific 3D Bioprinting Market Value Share Analysis, by Component, 2023 and 2034
Figure 40: Asia Pacific 3D Bioprinting Market Value Share Analysis, by Application, 2023 and 2034
Figure 41: Asia Pacific 3D Bioprinting Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific 3D Bioprinting Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific 3D Bioprinting Market Attractiveness Analysis, by Application, 2024-2034
Figure 44: Asia Pacific 3D Bioprinting Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America 3D Bioprinting Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America 3D Bioprinting Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America 3D Bioprinting Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America 3D Bioprinting Market Value Share Analysis, by Component, 2023 and 2034
Figure 49: Latin America 3D Bioprinting Market Value Share Analysis, by Application, 2023 and 2034
Figure 50: Latin America 3D Bioprinting Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America 3D Bioprinting Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America 3D Bioprinting Market Attractiveness Analysis, by Application, 2024-2034
Figure 53: Latin America 3D Bioprinting Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa 3D Bioprinting Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa 3D Bioprinting Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa 3D Bioprinting Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa 3D Bioprinting Market Value Share Analysis, by Component, 2023 and 2034
Figure 58: Middle East & Africa 3D Bioprinting Market Value Share Analysis, by Application, 2023 and 2034
Figure 59: Middle East & Africa 3D Bioprinting Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa 3D Bioprinting Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa 3D Bioprinting Market Attractiveness Analysis, by Application, 2024-2034
Figure 62: Middle East & Africa 3D Bioprinting Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
3D Bioprinting Market
